Mutations in the neurofibromatosis type 1 (NF1 tumor suppressor gene are common in cancer, and can cause resistance to therapy. Using transcriptome analysis we identified MAF as an NF1 regulated transcription factor, and verified MAF regulation through RAS/MAPK/AP-1 signaling in malignant peripheral nerve sheath tumor (MPNST) cell lines. MAF was also downregulated in human MPNST. Acute re-expression of MAF promoted expression of glial differentiation markers in MPNST cells in vitro, decreased self-renewal of embryonic precursors and transiently affected tumor cell phenotypes in vitro by increasing MPNST cell death and reducing metabolic activity and anchorage independent growth. Paradoxically, chronic MAF overexpression enhanced MPNST cell ...
<div><p>Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often a...
Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas which lack effe...
Maf1 was initially identified as a transcriptional repressor of RNA pol III-transcribed genes, yet l...
Neurofibromatosis, type 1 (NF1) is a tumor predisposition syndrome affecting about 1 in 2500 live bi...
International audienceApproximately 30-50% of individuals with Neurofibromatosis type 1 develop beni...
Neurofibromatosis type 1 (NF1) patients develop benign neurofibromas and malignant peripheral nerve ...
Neurofibromin 1-mutant (NF1-mutant) cancers are driven by excessive Ras signaling; however, there ar...
International audienceMalignant peripheral nerve sheath tumors (MPNST) are highly resistant sarcomas...
Type 1 neurofibromatosis (NF1) is a common autosomal dominant disorder that results in neuroectoderm...
Neurofibromatosis type 1 (NF1) and Neurofibromatosis type 2 (NF2) are both autosomal dominant tumor ...
2012-06-22Although Maf1 has been identified as a central negative regulator of transcription, little...
SummaryRetinoic acid (RA) induces differentiation of neuroblastoma cells in vitro and is used with v...
In patients with the genetic disorder Neurofibromatosis type 1 (NF1), the loss of the Ras GTPase-act...
<p><u>Nuclear Maf1 expression is decreased in PTEN negative human prostate and liver cancers.</u> Im...
Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often associate...
<div><p>Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often a...
Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas which lack effe...
Maf1 was initially identified as a transcriptional repressor of RNA pol III-transcribed genes, yet l...
Neurofibromatosis, type 1 (NF1) is a tumor predisposition syndrome affecting about 1 in 2500 live bi...
International audienceApproximately 30-50% of individuals with Neurofibromatosis type 1 develop beni...
Neurofibromatosis type 1 (NF1) patients develop benign neurofibromas and malignant peripheral nerve ...
Neurofibromin 1-mutant (NF1-mutant) cancers are driven by excessive Ras signaling; however, there ar...
International audienceMalignant peripheral nerve sheath tumors (MPNST) are highly resistant sarcomas...
Type 1 neurofibromatosis (NF1) is a common autosomal dominant disorder that results in neuroectoderm...
Neurofibromatosis type 1 (NF1) and Neurofibromatosis type 2 (NF2) are both autosomal dominant tumor ...
2012-06-22Although Maf1 has been identified as a central negative regulator of transcription, little...
SummaryRetinoic acid (RA) induces differentiation of neuroblastoma cells in vitro and is used with v...
In patients with the genetic disorder Neurofibromatosis type 1 (NF1), the loss of the Ras GTPase-act...
<p><u>Nuclear Maf1 expression is decreased in PTEN negative human prostate and liver cancers.</u> Im...
Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often associate...
<div><p>Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often a...
Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas which lack effe...
Maf1 was initially identified as a transcriptional repressor of RNA pol III-transcribed genes, yet l...